Company / Revenue per Share
Bionano Genomics, Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.28
FY2025
5-year range
$0.04 / $47.36
FY2021-FY2025
Trend
-67.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.94 to $15.28 over the past 2 years.
Based on SEC 10-K filings.
15.28 in FY2025 with a 5-year CAGR of +120.1%.
Improved from $0.94 to $15.28 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +442.0%
- 5-Year CAGR
- +120.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 67.7% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.28 | -67.7% |
| FY2024 | $47.36 | +4962.7% |
| FY2023 | $0.94 | +874.5% |
| FY2022 | $0.10 | +114.5% |
| FY2021 | $0.04 | -84.9% |
| FY2020 | $0.30 | -75.2% |
| FY2019 | $1.19 | -99.0% |
| FY2018 | $123.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026